T 100 (Tarceva 100 mg)

Generic Name: erlotinib

Pill imprint T 100 has been identified as Tarceva 100 mg.

Tarceva is used in the treatment of non-small cell lung cancer; renal cell carcinoma; pancreatic cancer and belongs to the drug class EGFR inhibitors. There is positive evidence of human fetal risk during pregnancy. Tarceva 100 mg is not subject to the Controlled Substances Act.

See also related documents.

Images for T 100 (Tarceva 100 mg)

Tarceva 100 mg T 100
Tarceva
Generic Name:
erlotinib
Imprint:
T 100
Strength:
100 mg
Color:
White
Size:
9.00 mm
Shape:
Round
Availability:
Prescription only
Drug Class:
EGFR inhibitors
Pregnancy Category:
D - Positive evidence of risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Genentech
National Drug Code (NDC):
50242-0063
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
54868-5474 Physicians Total Care Inc (repackager)

Note: Inactive ingredients may vary.

View Details Print Page

Pill Identifier

Search by Imprint, Shape or Color

Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

Search by Drug Name

Search by National Drug Codes (NDC)

Advanced Breast Cancer: Learn about treatments to improve quality of life. Click Here

Close
Hide
(web5)